β¨ Medicines Distribution Consent
1 SEPTEMBER 2011 NEW ZEALAND GAZETTE, No. 136 3885
Product: Ceftriaxone Pfizer
Active Ingredient: Ceftriaxone sodium 596mg equivalent to ceftriaxone 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Aurobindo Pharma Limited, Andhra Pradesh, India
Product: Ceftriaxone Pfizer
Active Ingredient: Ceftriaxone sodium 1193mg equivalent to ceftriaxone 1000mg
Dosage Form: Powder for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Aurobindo Pharma Limited, Andhra Pradesh, India
Product: Ceftriaxone Pfizer
Active Ingredient: Ceftriaxone sodium 2386mg equivalent to ceftriaxone 2000mg
Dosage Form: Powder for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Aurobindo Pharma Limited, Andhra Pradesh, India
Product: Oralair
Active Ingredient: Grass pollen extract 100IR
Dosage Form: 100 IR Sublingual tablet
Active Ingredient: Allergen extracts 300IR/mL
Dosage Form: 300 IR Sublingual tablet
New Zealand Sponsor: Ebos Group Limited
Manufacturer: Osny Pharma S.A.S, Osny, France
Product: Oralair
Active Ingredient: Grass pollen extract 300IR
Dosage Form: Sublingual tablet
New Zealand Sponsor: Ebos Group Limited
Manufacturer: Osny Pharma S.A.S, Osny, France
Product: Sensodyne Multi Action Isoactive Foaming Gel
Active Ingredients:
Potassium nitrate 5%w/w
Sodium fluoride 0.254%w/w equivalent to fluoride 1149ppm
Dosage Form: Toothpaste
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: Ultradent Products Inc, Utah, United States of America
Product: Sensodyne Whitening Isoactive Foaming Gel
Active Ingredients:
Potassium nitrate 5%w/w
Sodium fluoride 0.254%w/w equivalent to fluoride 1149ppm
Dosage Form: Toothpaste
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: Ultradent Products Inc, Utah, United States of America
Product: Soliris
Active Ingredient: Eculizumab 300mg
Dosage Form: Solution for infusion
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: DSM Pharmaceuticals Inc, North Carolina, United States of America
Dated this 25th day of August 2011.
DEBORAH KENT, Acting Deputy Director-General, Clinical Leadership, Protection and Regulation (pursuant to delegation given by the Minister of Health on 6 July 2001).
go5986
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare25 August 2011
Medicines, Distribution, Consent, Ceftriaxone, Oralair, Sensodyne, Soliris
- DEBORAH KENT, Acting Deputy Director-General, Clinical Leadership, Protection and Regulation
NZ Gazette 2011, No 136